Accelerating discovery through NHS partnerships

Strategic Research Agreements

Sensyne Health collaborates with NHS Trusts under strategic research agreements (SRAs) to combine clinical artificial intelligence technology (Clinical AI) with ethically-sourced, anonymised patient data to help improve patient care, accelerate the discovery and development of new medicines and improve our understanding of disease and treatment.  

Our current SRA partnerships include:

We have also signed conditional strategic research agreements with George Eliot NHS Trust and Wye Valley NHS Trust and we are in discussions with a number of other NHS Trusts regarding similar agreements.

Supporting the UK Industrial Strategy in Life Sciences

Sensyne Health is a strong supporter of the Government’s efforts to develop a national approach to health data analysis and enable innovation that accelerates medical research and delivers patient benefit – as demonstrated by our SEND and GDm-Health technologies, which are already in use across multiple NHS Trusts.

We believe it is imperative that the UK retains its position as a leader in this rapidly developing sector.  NHS patient data is the best in the world because of the free, single provider healthcare system that we have in the UK. Clinical AI using anonymised patient data has the potential to lead to significant healthcare benefits, including improving patient outcomes and speeding up the medicine discovery and development process, ultimately alleviating pressure on the NHS.